Selecting nonpharmaceutical interventions for influenza

Risk Analysis

Volumn 33, Issue 8, 2013, Pages 1473-1488

  Jones, Rachael M ^a   Adida, Elodie ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Costbenefit; Disease transmission model; Hygiene interventions; Intervention compliance; Social distancing

Indexed keywords

COSTBENEFIT; DISEASE TRANSMISSION; HYGIENE INTERVENTIONS; INTERVENTION COMPLIANCE; SOCIAL DISTANCING;

PHYSIOLOGY; RISK ANALYSIS; SAFETY ENGINEERING;

DISEASE CONTROL;

DECISION MAKING; DISEASE CONTROL; DISEASE RESISTANCE; DISEASE TRANSMISSION; EPIDEMIC; HYGIENE; INFECTIOUS DISEASE; INFLUENZA; NUMERICAL MODEL; PROBABILITY; SOCIAL BEHAVIOR;

ADULT; ARTICLE; COSTBENEFIT; DISEASE TRANSMISSION; DISEASE TRANSMISSION MODEL; EPIDEMIC; HUMAN; HUMAN RELATION; HYGIENE; HYGIENE INTERVENTIONS; INFLUENZA; INTERVENTION COMPLIANCE; MASK; METHODOLOGY; PATIENT CARE; PREVENTIVE MEDICINE; PROBABILITY; PUBLIC HEALTH; SOCIAL DISTANCING; THEORETICAL MODEL; YOUNG ADULT;

COSTBENEFIT; DISEASE TRANSMISSION MODEL; HYGIENE INTERVENTIONS; INTERVENTION COMPLIANCE; SOCIAL DISTANCING;

ADULT; DISEASE OUTBREAKS; HUMANS; HYGIENE; INFLUENZA, HUMAN; INTERPERSONAL RELATIONS; MASKS; MODELS, THEORETICAL; PATIENT ISOLATION; PREVENTIVE MEDICINE; PROBABILITY; PUBLIC HEALTH; YOUNG ADULT;

EID: 84882639142     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2012.01938.x     Document Type: Article

References (38)

1. Longini Jr. IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DAT, Halloran ME. Containing pandemic influenza at the source. Science, 2005; 309(5737):1083-1087.
2. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature, 2006; 442, 448-452.
3. Arino J, Brauer F, van den Driessche P, Watmough J, Wu J. A model for influenza with vaccination and antiviral treatment. Journal of Theoretical Biology, 2008; 253:118-130.
4. Davey VJ, Glass RJ, Min HJ, Beyeler WE, Glass LM. Effective, robust design of community mitigation for pandemic influenza: A systematic examination of proposed US guidance. PLoS ONE, 2008; 3(7):e2606. doi:10.137/journal.pone.0002606.
5. Kernéis S, Grais RF, Boelle PY, Flahault A, Vergu E. Does the effectiveness of control measures depend on the influenza pandemic profile. PLoS ONE, 2008; 3(1):e1748. doi:10.1371/journal.pone.0001478.
6. Brienen NCJ, Timen A., Wallinga J, van Steenbergen JE, Teunis PFM. The effect of mask use on the spread of influenza during a pandemic. Risk Analysis, 2010; 30:1210-1218.
7. Tracht SM, Del Valle SY, Hyman JM. Mathematical modeling of the effectiveness of facemasks in reducing the spread of novel influenza A (H1N1). PLoS ONE, 2010; 5(2):e9018.
8. Hessel L, European Vaccine Manufacturers (EVM) Influenza Working Group. Pandemic influenza vaccines: Meeting the supply, distribution and deployment challenges. Influenza and Other Respiratory Viruses, 2009; 3(4):165-170.
9. Liao Q, Cowling BJ, Lam WWT, Fielding R. Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: A longitudinal study. PLoS ONE, 2011; 6(3):e17713. doi:10.1371/journal.pone.0017713.
10. Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, Bolotin S, Vipond I, Muir P, Guiver M, McMenamin J, Reynolds A, Moore C, Gunson R, Thompson C, Galiano M, Bermingham A, Ellis J, Zambon M. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveillance, 2011; 16(5):19784.
11. Tellier R. Review of aerosol transmission of influenza A virus. Emerging Infectious Diseases, 2006; 12(11):1657-1662.
12. Teunis PFM, Brienen N, Kretzschmar MEE. High infectivity and pathogenicity of influenza A virus via aerosol and droplet transmission. Epidemics, 2010; 2(4):215-222.
13. Jones RM, Adida E. Influenza infection risk and predominate exposure route: Uncertainty analysis. Risk Analysis, 2011; 31(4), doi: 10.1111/j.1539-6924.2011.01600.x
14. Larson EL, Ferng YH, Wong-McLoughlin J, Wang S, Haber M, Morse SS. Impact of non-pharmaceutical interventions on URIs and influenza in crowded, urban households. Public Health Reports, 2010; 125:178-191.
15. Stebbins S, Stark JH, Vukotich Jr CJ. Compliance with a multilayered nonpharmaceutical intervention in an urban elementary school setting. Journal of Public Health Management and Practice, 2010; 16(4):316-324.
16. Simmerman JM, Suntarattiwong P, Levy J, Jarman RG, Kaewchana S, Gibbons RB, Cowling BJ, Sanasuttipun W, Maloney SA, Uyeki TM, Kamimoto L, Chotipitayasunondh T. Findings from a household randomized controlled trial of hand washing and face masks to reduce influenza transmission in Bangkok, Thailand. Influenza and Other Respiratory Viruses, 2011; 5(4):256-267.
17. Larson RC. Simple models of influenza progression within a heterogeneous population. Operations Research, 2007; 55(3):399-412.
18. Nicas M, Jones RM. Relative contributions of four exposure pathways to influenza infection risk. Risk Analysis, 2009; 29:1292-1303.
19. Longini IM, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. American Journal of Epidemiology, 2004; 59:623-633.
20. Mossong J, Hens N, Jit M, Beutels P, Auranen R, Massari M, Salmaso S, Scalia Tomba G, Wallingam J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine, 2008; 5(3):e74. doi:10.1371/journal.pmed.0050074.
21. Kitajima M, Huang Y, Watanabe T, Katayma H, Haas CN. Dose-response time modelling for highly pathogenic avian influenza A (H5N1) virus infection. Letters in Applied Microbiology, 2011; 53:438-444.
22. Bollinger N. NIOSH Respirator Selection Logic. DHHS (NIOSH) Publication No. 2005-100, 2004.
23. Reponen T, Lee SA, Grinshpun SA, Johnson E, McKay R. Effect of fit testing on the protection offered by N95 filtering facepiece respirators against fine particles in a laboratory setting. Annals of Occupational Hygiene, 2011; 55(3): 264-271.
24. van der Sande M, Teunis P, Sabel R. Professional and home-made face masks reduce exposure to respiratory infections among the general population. PLoS ONE, 2008; 3(7):e2618. doi:10.1371/journal.pone.0002618.
25. Rengasamy S, Eimer B, Shaffer RE. Simple respiratory protection-Evaluation of the filtration performance of cloth masks and common fabric materials against 20-1000 nm size particles. Annals of Occupational Hygiene, 2010; 54(7):789-798.
26. Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France and Australia: Transmission and prospects for control. Epidemiology and Infection, 2008; 136:852-864.
27. Chowell G, Echevarria-Zuno S, Viboud C, Simonsen L, Tamerius J, Miller MA, Broja-Aburto VH. Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Medicine, 2009; 8(5):e1000436.
28. Rothberg MB, Rose DN. Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysis. American Journal of Medicine, 2005; 118:68-77.
29. Molinari NAM, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Brdiges CB. 2007 The annual impact of seasonal influenza in the US: Measuring disease burden and costs. Vaccine, 2007; 25(27):5086-5096.
30. Cowling BJ, Fung ROP, Cheng CKY, Fang VJ, Chan KH, Seto WH, Yung R, Chiu B, Lee P, Uyeki TM, Houck PM, Malik Peiris JS, Leung GM. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One, 2008; 3(5):e2101.
31. Cowing BJ, Chan KH, Fang VJ, Cheng CKY, Fung ROP, Wai W, Sin J, Seto WH, Yung R, Chu DWS, Chiu BCF, Lee PWY, Chiu MC, Lee HC, Uyeki TM, Houck RM, Malik Peiris JS, Leung GM. 2009 Facemasks and hand hygiene to prevent influenza transmission in households: A cluster randomized trial. Annals of Internal Medicine, 2009; 15:437-446.
32. Park JH, Cheong HK, Son DY, Kim SU, Ha CM. Perceptions and behaviors related to hand hygiene for the prevention of H1N1 influenza transmission among Korean university students during the peak pandemic period. BMC Infectious Diseases, 2010; 10:222.
33. Condon BJ, Sinha T. Who is that masked person: The use of face masks on Mexico City public transportation during the influenza A (H1N1) outbreak. Health Policy, 2010; 95:50-56.
34. Agüero F, Adell MN, Pérez Geiménez, López Medina MJ, Garcia Continente X. Adpotion of preventive measures during and after the 2009 influenza A (H1N1) virus pandemic peak in Spain. Preventive Medicine, 2011; 53:203-206.
35. Li S, Eisenberg JNS, Spicknall IH, Koopman JS. Dynamics and control of infections transmission from person to person through the environment. American Journal of Epidemiology, 2009; 170(2):257-265.
36. Spicknall IH, Koopman JS, Nicas M, Pujol JM, Li S, Eisenberg JNS. Informing optimal environmental influenza interventions: How the host, agent and environment alter dominant routes of transmission. PLoS Computational Biology, 2010; 6(10):e1000969.
37. Eames KTD, Tilston NL, White PJ, Adams E, Edmunds WJ. The impact of illness and the impact of school closure on social contact patterns. Health Technology Assessment, 2010; 14:267-312.
38. Kretzschmar M, Mikolajczyk RT. Contact profiles in eight European countries and implications for modelling the spread of airborne infectious diseases. PLoS One, 2009; 4(60):e5931. doi:10.1371/journal.pone.0005931.